1Nash K, Hafeez A, Hou S. Hospital - acquired renal insufficiency [J]. Am J Kidney Dis, 2002, 39: 930-936.
2Trivedi HS, Moore H, Nasr S, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephretoxicity [J]. Nephren Clin Praet, 2003, 93:C29-C34.
3Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology [ J ]. Am J Roentgenol, 2003, 181 : 1463 - 1471.
5Kay J, Chow WH, Chan TM, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial [ J ]. JAMA, 2003, 289 : 606 - 608.
6Zagler A, Azadpour M, Mercado C, et al. N - acetylcysteine and contrast- induced nephropathy: a meta - analysis of 13 randomized trials [J]. Am Heart J, 2006, 151: 140-145.
7Spargias K, Alexopoulos E, Kyrzopoulos S, et al. Ascorbic acid prevents contrast - mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention [ J ]. Circulation, 2004, 110:2837-2842.
8Patti G, Nusca A, Chello M, et al. Usefulness of statin pretreatment to prevent contrast - induced nephropathy and to improve long - term outcome in patients undergoing percutaneous coronary intervention [ J ]. Am J Cardiol, 2008, 101 : 279 -285.
9Jo SH, Koo BK, Park JS, et al. Prevention of radiocontrast medium - induced nephropathy using short - term high - dose simvastatin in patients with renal insufficiency undergoing coronary angiography ( PROMISS) trial- a randomized controlled study [J]. Am Heart J, 2008, 155 (3) : 499. e1 -e8.
